Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant …

T Gaillard, M Boxberger, M Madamet, B Pradines - Malaria journal, 2018 - Springer
Abstract According to the World Health Organization (WHO), Plasmodium falciparum malaria
during pregnancy is responsible for deleterious consequences for the mother and her child …

Antimalarial drugs–what is in use and what is in the pipeline

M Schlitzer - Archiv der Pharmazie: An International Journal …, 2008 - Wiley Online Library
Malaria continues to be a potentially fatal threat to almost half of the world's population. In
light of this threat, the armory to fight this disease is rather limited. Resistance against the …

KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission

KL Kuhen, AK Chatterjee, M Rottmann… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Renewed global efforts toward malaria eradication have highlighted the need for novel
antimalarial agents with activity against multiple stages of the parasite life cycle. We have …

Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established …

R Tahar, L Vivas, L Basco, E Thompson… - Journal of …, 2011 - academic.oup.com
Objectives Indolone-N-oxides are characterized by the presence of a highly reactive
pharmacophore, the nitrone moiety (C= N+-O−), which undergoes oxidation-reduction …

The safety of antimalarial drugs in pregnancy

PA Phillips-Howard, D Wood - Drug safety, 1996 - Springer
Alternative drugs to chloroquine are required to prevent the deleterious effects of malaria in
pregnancy. Fear of potential toxicity has limited antimalarial drug use in pregnancy. Animal …

Emerging drugs for malaria

S Tschan, PG Kremsner… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Malaria remains one of the most important infectious diseases, causing around
655 000 deaths annually, mostly among children in Sub-Saharan Africa. Plasmodium …

Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria

F Macintyre, H Ramachandruni, JN Burrows, R Holm… - Malaria journal, 2018 - Springer
Over the last 15 years, the majority of malaria drug discovery and development efforts have
focused on new molecules and regimens to treat patients with uncomplicated or severe …

Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development

M Schlitzer - ChemMedChem: Chemistry Enabling Drug …, 2007 - Wiley Online Library
Since ancient times, humankind has had to struggle against the persistent onslaught of
pathogenic microorganisms. Nowadays, malaria is still the most important infectious disease …

Drugs in development for malaria

EA Ashley, AP Phyo - Drugs, 2018 - Springer
The last two decades have seen a surge in antimalarial drug development with product
development partnerships taking a leading role. Resistance of Plasmodium falciparum to the …

New therapies for malaria

PM Woster - 2003 - Elsevier
Publisher Summary This chapter focuses on the new therapies for malaria. Malaria is one of
the world's most deadly diseases that threatens 40% of the world's population and infects …